CG Oncology Announces New Board Member and Board Transition [Yahoo! Finance]
CG Oncology Announces New Board Member and Board Transition
CG Oncology to Present Results on Cretostimogene Grenadenorepvec at the Society of Urologic Oncology (SUO) 26th Annual Meeting [Yahoo! Finance]
CG Oncology to Present Results on Cretostimogene Grenadenorepvec at the Society of Urologic Oncology (SUO) 26th Annual Meeting
CG Oncology (NASDAQ:CGON) was given a new $62.00 price target on by analysts at Truist Financial Corporation.